Nathalie Tremblay
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nathalie Tremblay.
Biochimica et Biophysica Acta | 2000
Mark Abramovitz; Mohammed Adam; Yves Boie; Marie-Claude Carrière; Danielle Denis; Claude Godbout; Sonia Lamontagne; C. Rochette; Nicole Sawyer; Nathalie Tremblay; Michel Belley; Michel Gallant; Claude Dufresne; Yves Gareau; Rejean Ruel; Helene Juteau; Marc Labelle; Nathalie Ouimet; Kathleen M. Metters
Stable cell lines that individually express the eight known human prostanoid receptors (EP(1), EP(2), EP(3), EP(4), DP, FP, IP and TP) have been established using human embryonic kidney (HEK) 293(EBNA) cells. These recombinant cell lines have been employed in radioligand binding assays to determine the equilibrium inhibitor constants of known prostanoid receptor ligands at these eight receptors. This has allowed, for the first time, an assessment of the affinity and selectivity of several novel compounds at the individual human prostanoid receptors. This information should facilitate interpretation of pharmacological studies that employ these ligands as tools to study human tissues and cell lines and should, therefore, result in a greater understanding of prostanoid receptor biology.
Bioorganic & Medicinal Chemistry | 2001
Helene Juteau; Yves Gareau; Marc Labelle; Claudio Sturino; Nicole Sawyer; Nathalie Tremblay; Sonia Lamontagne; Marie-Claude Carrière; Danielle Denis; Kathleen M. Metters
Potent and selective antagonists of the human EP3 receptor have been identified. The structure-activity relationship of the chemical series was conducted and we found several analogues displaying sub-nanomolar K(i) values at the EP3 receptor and micromolar activities at the EP1, EP2 and EP4 receptors. The effect of added human serum albumin (HSA) on the binding affinity at the EP3 receptor was also investigated.
Bioorganic & Medicinal Chemistry Letters | 1996
Yves Gareau; Claude Dufresne; Michel Gallant; C. Rochette; Nicole Sawyer; Deborah Slipetz; Nathalie Tremblay; Philip K. Weech; Kathleen M. Metters; Marc Labelle
A series of Δ8-tetrahydrocannabinol (THC) and biphenylic derivatives were prepared and their binding affinity for both human cannabinoid receptors hCB1 and hCB2 evaluated.
Bioorganic & Medicinal Chemistry Letters | 1996
Michel Gallant; Claude Dufresne; Yves Gareau; Daniel Guay; Yves Leblanc; Petpiboon Prasit; C. Rochette; Nicole Sawyer; Deborah Slipetz; Nathalie Tremblay; Kathleen M. Metters; Marc Labelle
Abstract A new class of potent ligand for the human peripheral cannabinoid (hCB 2 ) receptor is described. Two indole analogs 13 and 17 exhibited nanomolar potencies (K i ) with good selectivity for the hCB 2 receptor over the human central cannabinoid (hCB 1 ) receptor.
Bioorganic & Medicinal Chemistry Letters | 2002
Michel Gallant; Marie-Claude Carrière; Anne Chateauneuf; Danielle Denis; Yves Gareau; Claude Godbout; Gillian Greig; Helene Juteau; Nicolas Lachance; Patrick Lacombe; Sonia Lamontagne; Kathleen M. Metters; C. Rochette; Rejean Ruel; Deborah Slipetz; Nicole Sawyer; Nathalie Tremblay; Marc Labelle
Potent and selective ligands for the human EP3 prostanoid receptor are described. Biaryl compounds bearing a tethered ortho substituted acidic moiety were identified as potent EP3 antagonists based on the SAR described herein. The binding affinity of key compounds on all eight human prostanoid receptors is reported.
Progress in Lipid Research | 1991
Philip K. Weech; Pierre Provost; Nathalie Tremblay; Rino N. Camato; Ross W. Milne; Yves L. Marcel; Eric Rassart
The structure of ApoD and its sites of synthesis have been discovered. These characteristics differ from those of the other apolipoproteins. The role of ApoD in the plasma lipoprotein system remains to be discovered, but the recent, rapid increase in our knowledge of this protein suggests that it plays an important role in the homeostasis or housekeeping of probably all organs. One of its functions is likely to be the transport of a hydrophobic ligand (a lipid) in a one-to-one molar ratio with itself. This transport is likely to occur unidirectionally between neighboring cells in an organ, and between perivascular cells and the blood circulation. The chemical structure of the natural ligand, or ligands, of ApoD in normal cells in vivo or in culture is not known, but ApoD has been shown to bind some steroids and bilirubin. Remarkable upregulation of synthesis of ApoD has been observed during regeneration of injured peripheral nerves. Perhaps the physiologic role of ApoD will prove to be more interesting and of equal importance in biology to the roles of the other apolipoproteins in cardiovascular disease.
Bioorganic & Medicinal Chemistry Letters | 1999
Rejean Ruel; Patrick Lacombe; Mark Abramovitz; Claude Godbout; Sonia Lamontagne; C. Rochette; Nicole Sawyer; Rino Stocco; Nathalie Tremblay; Kathleen M. Metters; Marc Labelle
A new class of potent and selective ligands for the human EP1 prostanoid receptor is described. SAR studies reported herein allowed the identification of several potent dibenzazocinones bearing an acylsulfonamide side chain. The binding affinity of these compounds on all eight human prostanoid receptors is reported.
Bioorganic & Medicinal Chemistry Letters | 2001
Helene Juteau; Yves Gareau; Marc Labelle; Sonia Lamontagne; Nathalie Tremblay; Marie-Claude Carrière; Nicole Sawyer; Danielle Denis; Kathleen M. Metters
Potent and selective EP3 receptor ligands were found by making a library using solid-support chemistry. These compounds can be obtained by a Suzuki coupling reaction of a solid-supported benzyl bromide using various boronic acids. The yields obtained for this reaction were in the range of 24-95% of arylmethyl cinnamic acid 1 after cleavage from the Wang resin.
Biochemical and Biophysical Research Communications | 1992
Nathalie Tremblay; Donald W. Nicholson; Michel Potier; Philip K. Weech
We have studied the cytosolic phospholipase A2 (cPLA2) of human U937 cells by radiation inactivation in order to characterize the functional form of the native enzyme by a method that was independent of the discrepancies observed by SDS-PAGE and cDNA cloning. The Radiation Inactivation Size of cPLA2 was reproducible and gave a value of 76,800-80,100 daltons. We eluted the active enzyme from polyacrylamide-gradient gel electrophoresis at a molecular weight of 77,000, confirming the irradiation result. We conclude that cPLA2 is active as the monomeric enzyme and is composed of a single major functional domain that is sensitive to irradiation.
Biochemistry | 1993
Ian P. Street; Hung Kuei Lin; Farideh Ghomashchi; Zhaoyin Wang; Helene Perrier; Nathalie Tremblay; Zheng Huang; Philip K. Weech; Michael H. Gelb